Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (495)
|
Core Tip (543)
|
Full Article (HTML) (2037)
|
Figures (1-1) (363)
|
Full Article (PDF)-1204K (143)
|
Full Article with Cover (PDF)-11949K (117)
|
Full Article (XML)-236K (82)
|
Audio-1342K (6)
|
Peer-Review Report-230K (84)
|
Answering Reviewers-97K (75)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5670)
|
Similar Articles (75)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (523)
|
Core Tip (569)
|
Full Article (HTML) (1407)
|
Tables (1-1) (450)
|
Full Article (PDF)-358K (123)
|
Full Article with Cover (PDF)-11106K (131)
|
Full Article (XML)-54K (74)
|
Audio-1072K (9)
|
Peer-Review Report-236K (71)
|
Answering Reviewers-62K (66)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4689)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (581)
|
Core Tip (480)
|
Full Article (HTML) (4805)
|
Figures (1-2) (392)
|
Tables (1-5) (368)
|
Full Article (PDF)-1655K (219)
|
Full Article with Cover (PDF)-12399K (157)
|
Full Article (XML)-226K (77)
|
Audio-1259K (9)
|
Peer-Review Report-216K (81)
|
Answering Reviewers-145K (76)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (12)
|
Total Visits (8223)
|
Similar Articles (63)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (589)
|
Core Tip (511)
|
Full Article (HTML) (3212)
|
Figures (1-1) (391)
|
Full Article (PDF)-601K (229)
|
Full Article with Cover (PDF)-11346K (96)
|
Full Article (XML)-89K (83)
|
Audio-384K (5)
|
Peer-Review Report-180K (69)
|
Answering Reviewers-74K (72)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (6357)
|
Similar Articles (334)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (564)
|
Core Tip (504)
|
Article Highlights (537)
|
Full Article (HTML) (2057)
|
Figures (1-4) (355)
|
Tables (1-3) (345)
|
Full Article (PDF)-1672K (127)
|
Full Article with Cover (PDF)-12418K (124)
|
Full Article (XML)-173K (73)
|
Audio-467K (6)
|
Peer-Review Report-182K (65)
|
Answering Reviewers-71K (96)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6323)
|
Similar Articles (2000)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (546)
|
Core Tip (547)
|
Article Highlights (639)
|
Full Article (HTML) (1880)
|
Figures (1-3) (411)
|
Tables (1-2) (378)
|
Full Article (PDF)-1874K (120)
|
Full Article with Cover (PDF)-12619K (106)
|
Full Article (XML)-114K (68)
|
Audio-386K (11)
|
Peer-Review Report-233K (88)
|
Answering Reviewers-161K (77)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7176)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (472)
|
Core Tip (463)
|
Article Highlights (530)
|
Full Article (HTML) (1334)
|
Figures (1-4) (334)
|
Full Article (PDF)-5746K (112)
|
Full Article with Cover (PDF)-16492K (95)
|
Full Article (XML)-96K (74)
|
Audio-3997K (6)
|
Peer-Review Report-192K (66)
|
Answering Reviewers-146K (70)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4809)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (521)
|
Core Tip (502)
|
Article Highlights (536)
|
Full Article (HTML) (2342)
|
Figures (1-4) (336)
|
Tables (1-5) (357)
|
Full Article (PDF)-6006K (151)
|
Full Article with Cover (PDF)-16750K (111)
|
Full Article (XML)-200K (74)
|
Audio-376K (3)
|
Peer-Review Report-182K (84)
|
Answering Reviewers-60K (87)
|
Supplementary Material-355K (86)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7877)
|
Similar Articles (1852)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (479)
|
Core Tip (543)
|
Article Highlights (546)
|
Full Article (HTML) (1544)
|
Figures (1-4) (352)
|
Tables (1-4) (353)
|
Full Article (PDF)-5941K (113)
|
Full Article with Cover (PDF)-16687K (102)
|
Full Article (XML)-115K (69)
|
Audio-187K (9)
|
Peer-Review Report-215K (65)
|
Answering Reviewers-37K (78)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6339)
|
Similar Articles (2462)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (507)
|
Core Tip (504)
|
Full Article (HTML) (1253)
|
Figures (1-1) (422)
|
Full Article (PDF)-5068K (109)
|
Full Article with Cover (PDF)-15813K (97)
|
Full Article (XML)-63K (63)
|
Audio-811K (3)
|
Peer-Review Report-266K (77)
|
Answering Reviewers-225K (78)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5080)
|
Similar Articles (4231)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (501)
|
Core Tip (508)
|
Full Article (HTML) (1277)
|
Full Article (PDF)-325K (101)
|
Full Article with Cover (PDF)-11079K (82)
|
Full Article (XML)-24K (77)
|
Audio-243K (1)
|
Peer-Review Report-215K (56)
|
Answering Reviewers-19K (57)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3610)
|
Similar Articles (393)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open